Skip to main content
Top
Published in: BMC Cancer 1/2011

Open Access 01-12-2011 | Research article

The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada

Authors: Morteza Bashash, T Greg Hislop, Amil M Shah, Nhu Le, Angela Brooks-Wilson, Chris D Bajdik

Published in: BMC Cancer | Issue 1/2011

Login to get access

Abstract

Background

Gastric and esophageal cancers are among the most lethal human malignancies. Their epidemiology is geographically diverse. This study compares the survival of gastric and esophageal cancer patients among several ethnic groups including Chinese, South Asians, Iranians and Others in British Columbia (BC), Canada.

Methods

Data were obtained from the population-based BC Cancer Registry for patients diagnosed with invasive esophageal and gastric cancer between 1984 and 2006. The ethnicity of patients was estimated according to their names and categorized as Chinese, South Asian, Iranian or Other. Cox proportional hazards regression analysis was used to estimate the effect of ethnicity adjusted for patient sex and age, disease histology, tumor location, disease stage and treatment.

Results

The survival of gastric cancer patients was significantly different among ethnic groups. Chinese patients showed better survival compared to others in univariate and multivariate analysis. The survival of esophageal cancer patients was significantly different among ethnic groups when the data was analyzed by a univariate test (p = 0.029), but not in the Cox multivariate model adjusted for other patient and prognostic factors.

Conclusions

Ethnicity may represent underlying genetic factors. Such factors could influence host-tumor interactions by altering the tumor's etiology and therefore its chance of spreading. Alternatively, genetic factors may determine response to treatments. Finally, ethnicity may represent non-genetic factors that affect survival. Differences in survival by ethnicity support the importance of ethnicity as a prognostic factor, and may provide clues for the future identification of genetic or lifestyle factors that underlie these observations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians. 2005, 55 (2): 74-108. 10.3322/canjclin.55.2.74. Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians. 2005, 55 (2): 74-108. 10.3322/canjclin.55.2.74.
2.
go back to reference Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006, 24 (14): 2137-2150. 10.1200/JCO.2005.05.2308.CrossRefPubMed Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006, 24 (14): 2137-2150. 10.1200/JCO.2005.05.2308.CrossRefPubMed
4.
go back to reference Allen JW, Richardson JD, Edwards MJ: Squamous cell carcinoma of the esophagus: a review and update. SurgOncol. 1997, 6 (4): 193-200. Allen JW, Richardson JD, Edwards MJ: Squamous cell carcinoma of the esophagus: a review and update. SurgOncol. 1997, 6 (4): 193-200.
5.
6.
go back to reference BC Stats MoLaCS: Ethnicity and Visible Minority Characteristics of BC's Population. Infoline Report. 2008, 8-39. BC Stats MoLaCS: Ethnicity and Visible Minority Characteristics of BC's Population. Infoline Report. 2008, 8-39.
7.
go back to reference Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M, Malekzadeh R: Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006, 7 (1): 86-90.PubMed Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M, Malekzadeh R: Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006, 7 (1): 86-90.PubMed
8.
go back to reference Barekat AA, Saidi F, Dutz W: Cancer survey in south Iran with special reference to gastrointestinal neoplasms. IntJ Cancer. 1971, 7 (2): 353-363. 10.1002/ijc.2910070221.CrossRef Barekat AA, Saidi F, Dutz W: Cancer survey in south Iran with special reference to gastrointestinal neoplasms. IntJ Cancer. 1971, 7 (2): 353-363. 10.1002/ijc.2910070221.CrossRef
9.
go back to reference Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, et al: Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. IntJCancer. 2003, 107 (1): 113-118. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, et al: Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. IntJCancer. 2003, 107 (1): 113-118.
10.
go back to reference Fritz AG: International classification of diseases for oncology: Icd-o. 2000, Geneva: World Health Organization, 3 Fritz AG: International classification of diseases for oncology: Icd-o. 2000, Geneva: World Health Organization, 3
11.
go back to reference Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta PatholMicrobiolScand. 1965, 64: 31-49. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta PatholMicrobiolScand. 1965, 64: 31-49.
12.
go back to reference Henson DE, Dittus C, Younes M, Nguyen H, bores-Saavedra J: Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. ArchPathol Lab Med. 2004, 128 (7): 765-770. Henson DE, Dittus C, Younes M, Nguyen H, bores-Saavedra J: Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. ArchPathol Lab Med. 2004, 128 (7): 765-770.
13.
go back to reference Hislop GT, Bajdik CD, Regier MD, Barroetavena MC: Ethnic differences in survival for female cancers of the breast, cervix and colorectum in British Columbia, Canada. Asian Pac J Cancer Prev. 2007, 8 (2): 209-214.PubMed Hislop GT, Bajdik CD, Regier MD, Barroetavena MC: Ethnic differences in survival for female cancers of the breast, cervix and colorectum in British Columbia, Canada. Asian Pac J Cancer Prev. 2007, 8 (2): 209-214.PubMed
14.
go back to reference Hislop TG, Bajdik CD, Saroa SR, Yeole BB, Barroetavena MC: Cancer incidence in Indians from three areas: Delhi and Mumbai, India, and British Columbia, Canada. J Immigr Minor Health. 2007, 9 (3): 221-227. 10.1007/s10903-006-9035-5.CrossRefPubMed Hislop TG, Bajdik CD, Saroa SR, Yeole BB, Barroetavena MC: Cancer incidence in Indians from three areas: Delhi and Mumbai, India, and British Columbia, Canada. J Immigr Minor Health. 2007, 9 (3): 221-227. 10.1007/s10903-006-9035-5.CrossRefPubMed
15.
go back to reference Yavari P, Barroetavena MC, Hislop TG, Bajdik CD: Breast cancer treatment and ethnicity in British Columbia, Canada. BMC Cancer. 2010, 10: 154-10.1186/1471-2407-10-154.CrossRefPubMedPubMedCentral Yavari P, Barroetavena MC, Hislop TG, Bajdik CD: Breast cancer treatment and ethnicity in British Columbia, Canada. BMC Cancer. 2010, 10: 154-10.1186/1471-2407-10-154.CrossRefPubMedPubMedCentral
16.
go back to reference Taylor VM, Hislop TG, Jackson JC, Tu SP, Yasui Y, Schwartz SM, Teh C, Kuniyuki A, Acorda E, Marchand A, et al: A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J Natl Cancer Inst. 2002, 94 (9): 670-677.CrossRefPubMedPubMedCentral Taylor VM, Hislop TG, Jackson JC, Tu SP, Yasui Y, Schwartz SM, Teh C, Kuniyuki A, Acorda E, Marchand A, et al: A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J Natl Cancer Inst. 2002, 94 (9): 670-677.CrossRefPubMedPubMedCentral
17.
go back to reference Choi BC, Hanley AJ, Holowaty EJ, Dale D: Use of surnames to identify individuals of Chinese ancestry. Am J Epidemiol. 1993, 138 (9): 723-734.PubMed Choi BC, Hanley AJ, Holowaty EJ, Dale D: Use of surnames to identify individuals of Chinese ancestry. Am J Epidemiol. 1993, 138 (9): 723-734.PubMed
18.
go back to reference Hage BH, Oliver RG, Powles JW, Wahlqvist ML: Telephone directory listings of presumptive Chinese surnames: an appropriate sampling frame for a dispersed population with characteristic surnames. Epidemiology. 1990, 1 (5): 405-408. 10.1097/00001648-199009000-00012.CrossRefPubMed Hage BH, Oliver RG, Powles JW, Wahlqvist ML: Telephone directory listings of presumptive Chinese surnames: an appropriate sampling frame for a dispersed population with characteristic surnames. Epidemiology. 1990, 1 (5): 405-408. 10.1097/00001648-199009000-00012.CrossRefPubMed
19.
go back to reference Yavari P, Hislop TG, Abanto Z: Methodology to identify Iranian immigrants for epidemiological studies. Asian Pac J Cancer Prev. 2005, 6 (4): 455-457.PubMed Yavari P, Hislop TG, Abanto Z: Methodology to identify Iranian immigrants for epidemiological studies. Asian Pac J Cancer Prev. 2005, 6 (4): 455-457.PubMed
21.
go back to reference Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C: Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. CanJGastroenterol. 2008, 22 (2): 143-148. Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C: Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. CanJGastroenterol. 2008, 22 (2): 143-148.
22.
go back to reference Potter JD: Morphogens, morphostats, microarchitecture and malignancy. NatRevCancer. 2007, 7 (6): 464-474. Potter JD: Morphogens, morphostats, microarchitecture and malignancy. NatRevCancer. 2007, 7 (6): 464-474.
23.
go back to reference Hunter K: Host genetics influence tumour metastasis. Nat Rev Cancer. 2006, 6 (2): 141-146. 10.1038/nrc1803.CrossRefPubMed Hunter K: Host genetics influence tumour metastasis. Nat Rev Cancer. 2006, 6 (2): 141-146. 10.1038/nrc1803.CrossRefPubMed
24.
go back to reference Arnold M, Razum O, Coebergh JW: Cancer risk diversity in non-western migrants to Europe: An overview of the literature. Eur J Cancer. 2010, 46 (14): 2647-2659. 10.1016/j.ejca.2010.07.050.CrossRefPubMed Arnold M, Razum O, Coebergh JW: Cancer risk diversity in non-western migrants to Europe: An overview of the literature. Eur J Cancer. 2010, 46 (14): 2647-2659. 10.1016/j.ejca.2010.07.050.CrossRefPubMed
25.
go back to reference Gospodarowicz M, O'Sullivan B: Prognostic factors in cancer. SeminSurgOncol. 2003, 21 (1): 13-18. Gospodarowicz M, O'Sullivan B: Prognostic factors in cancer. SeminSurgOncol. 2003, 21 (1): 13-18.
26.
go back to reference Gospodarowicz MK, O'Sullivan B, Sobin LH: Prognostic factors in cancer. 2006, Hoboken, NJ: Wiley-Liss, 3 Gospodarowicz MK, O'Sullivan B, Sobin LH: Prognostic factors in cancer. 2006, Hoboken, NJ: Wiley-Liss, 3
27.
go back to reference Lin J, Beerm DG: Molecular biology of upper gastrointestinal malignancies. SeminOncol. 2004, 31 (4): 476-486. Lin J, Beerm DG: Molecular biology of upper gastrointestinal malignancies. SeminOncol. 2004, 31 (4): 476-486.
28.
go back to reference Pacelli F, Papa V, Caprino P, Sgadari A, Bossola M, Doglietto GB: Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. AmSurg. 2001, 67 (7): 697-703. Pacelli F, Papa V, Caprino P, Sgadari A, Bossola M, Doglietto GB: Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. AmSurg. 2001, 67 (7): 697-703.
29.
go back to reference Siewert JR, Bottcher K, Stein HJ, Roder JD, Busch R: Problem of proximal third gastric carcinoma. World JSurg. 1995, 19 (4): 523-531. 10.1007/BF00294713.CrossRef Siewert JR, Bottcher K, Stein HJ, Roder JD, Busch R: Problem of proximal third gastric carcinoma. World JSurg. 1995, 19 (4): 523-531. 10.1007/BF00294713.CrossRef
30.
go back to reference Bashash M, Yavari P, Hislop TG, Shah A, Sadjadi A, Babaei M, Le N, Brooks-Wilson A, Malekzadeh R, Bajdik C: Comparison of two diverse populations, British Columbia, Canada, and Ardabil, Iran, indicates several variables associated with gastric and esophageal cancer survival. J Gastrointest Cancer. 2011, 42 (1): 40-45. 10.1007/s12029-010-9228-y.CrossRefPubMed Bashash M, Yavari P, Hislop TG, Shah A, Sadjadi A, Babaei M, Le N, Brooks-Wilson A, Malekzadeh R, Bajdik C: Comparison of two diverse populations, British Columbia, Canada, and Ardabil, Iran, indicates several variables associated with gastric and esophageal cancer survival. J Gastrointest Cancer. 2011, 42 (1): 40-45. 10.1007/s12029-010-9228-y.CrossRefPubMed
31.
go back to reference Ugur VI, Kara SP, Kucukplakci B, Demirkasimoglu T, Misirlioglu C, Ozgen A, Elgin Y, Sanri E, Altundag K, Ozdamar N: Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey. MedOncol. 2008, 25 (1): 63-68. Ugur VI, Kara SP, Kucukplakci B, Demirkasimoglu T, Misirlioglu C, Ozgen A, Elgin Y, Sanri E, Altundag K, Ozdamar N: Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey. MedOncol. 2008, 25 (1): 63-68.
32.
go back to reference Daly JM, Karnell LH, Menck HR: National Cancer Data Base report on esophageal carcinoma. Cancer. 1996, 78 (8): 1820-1828. 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z.CrossRefPubMed Daly JM, Karnell LH, Menck HR: National Cancer Data Base report on esophageal carcinoma. Cancer. 1996, 78 (8): 1820-1828. 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z.CrossRefPubMed
33.
go back to reference Byfield SA, Earle CC, Ayanian JZ, McCarthy EP: Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders. Cancer. 2009, 115 (19): 4595-4605. 10.1002/cncr.24487.CrossRefPubMed Byfield SA, Earle CC, Ayanian JZ, McCarthy EP: Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders. Cancer. 2009, 115 (19): 4595-4605. 10.1002/cncr.24487.CrossRefPubMed
34.
go back to reference Kim J, Sun CL, Mailey B, Prendergast C, Artinyan A, Bhatia S, Pigazzi A, Ellenhorn JD: Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann Oncol. 2010, 21 (1): 152-160. 10.1093/annonc/mdp290.CrossRefPubMed Kim J, Sun CL, Mailey B, Prendergast C, Artinyan A, Bhatia S, Pigazzi A, Ellenhorn JD: Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann Oncol. 2010, 21 (1): 152-160. 10.1093/annonc/mdp290.CrossRefPubMed
35.
go back to reference Gill S, Shah A, Le N, Cook EF, Yoshida EM: Asian Ethnicity-Related Differences in Gastric Cancer Presentation and Outcome Among Patients Treated at a Canadian Cancer Center. Journal of Clinical Oncology. 2003, 21 (11): 2070-2076. 10.1200/JCO.2003.11.054.CrossRefPubMed Gill S, Shah A, Le N, Cook EF, Yoshida EM: Asian Ethnicity-Related Differences in Gastric Cancer Presentation and Outcome Among Patients Treated at a Canadian Cancer Center. Journal of Clinical Oncology. 2003, 21 (11): 2070-2076. 10.1200/JCO.2003.11.054.CrossRefPubMed
36.
go back to reference Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, et al: Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 11 (2): 165-173. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, et al: Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 11 (2): 165-173.
37.
go back to reference Sankaranarayanan R, Black RJ, Parkin DM, International Agency for Research on Cancer, World Health Organization: Cancer survival in developing countries. 1998, Lyon Oxford: International Agency for Research on Cancer; Distributed by Oxford University Press Sankaranarayanan R, Black RJ, Parkin DM, International Agency for Research on Cancer, World Health Organization: Cancer survival in developing countries. 1998, Lyon Oxford: International Agency for Research on Cancer; Distributed by Oxford University Press
38.
go back to reference Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, et al: Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. ArchIran Med. 2007, 10 (1): 32-37. Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, et al: Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. ArchIran Med. 2007, 10 (1): 32-37.
39.
go back to reference Kagawa-Singer M, Dadia AV, Yu MC, Surbone A: Cancer, culture, and health disparities: time to chart a new course?. CA Cancer J Clin. 60 (1): 12-39. Kagawa-Singer M, Dadia AV, Yu MC, Surbone A: Cancer, culture, and health disparities: time to chart a new course?. CA Cancer J Clin. 60 (1): 12-39.
Metadata
Title
The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada
Authors
Morteza Bashash
T Greg Hislop
Amil M Shah
Nhu Le
Angela Brooks-Wilson
Chris D Bajdik
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2011
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-11-164

Other articles of this Issue 1/2011

BMC Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine